1Inaji H, Komoike Y, Motomura K, et al. Breast conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast Cancer,2002, 9( 1 ) :20-25.
2van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol,2001,19 (22) :4224-4237.
3Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide:preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol, 2003, 21(22) :4165-4174.
4Fukutomi T. Clinical practice and outcome of breast-conserving treatment: the effectiveness of preoperative systemic chemotherapy. Breast Cancer, 2006, 13(2) :147-151.
5Cunnick GH, Mokbel K. Skin-sparing mastectomy. Am J Surg, 2004,188(1) :78-84.
6Gouy S, Rouzier R, Missana MC, et al. Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival. Ann Surg Oncol, 2005, 12(2) :161-166.
7Foster RD, Esserman LJ, Anthony JP, et al. Skin-sparing mastectomy and immediate breast reconstruction:a prospective cohort study for the treatment of advanced stages of breast carcinoma.Ann Surg Oncol,2002, 9 ( 5 ) :462- 466.
8Vandeweyer E. Simultaneous nipple and areola reconstruction : a review of 50 cases. Acta Chir Belg, 2003, 103(6) :593-595.
9Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trail comparing total mastectomy, lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 2002, 347(16) :1233-1241.
10Malhotra V, Dorr VJ, Lyss AP, et al. Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer. Clin Breast Cancer, 2004, 5(5): 377-384.
